Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computerized tomography and adrenoleukomyeloneuropathy

B P O'Neill, G S Forbes

    Archives of Neurology
    |May 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Primary intramedullary spinal cord lymphoma.

    Neurology·2011
    Same author

    Intraocular use of rituximab.

    Eye (London, England)·2007
    Same author

    Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment.

    Lancet (London, England)·2003
    Same author

    Persistent chorea triggered by hyperglycemic crisis in diabetics.

    Movement disorders : official journal of the Movement Disorder Society·2001
    Same author

    The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group.

    Neuro-oncology·2001
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Computerized tomography (CT) scans reveal distinct differences between adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) subtypes. Recognizing these leukodystrophy patterns aids in diagnosis and biochemical testing.

    Area of Science:

    • Neurology
    • Radiology
    • Genetics

    Background:

    • Adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) are related X-linked genetic disorders affecting white matter.
    • These conditions, collectively known as leukodystrophies, present with varied neurological symptoms.
    • Accurate differentiation is crucial for appropriate patient management and prognosis.

    Observation:

    • This study examined five cases of adrenomyeloneuropathy to analyze the differential computerized tomographic (CT) appearances of ALD and AMN.
    • Adrenoleukodystrophy (ALD) typically shows distinctive CT findings due to predominant cerebral white matter involvement.
    • Adrenomyeloneuropathy (AMN) may present with nonspecific CT abnormalities, as it primarily affects spinal and peripheral white matter.

    Findings:

    Related Experiment Videos

  • CT scans can differentiate between ALD and AMN subtypes based on the pattern and location of white matter lesions.
  • Distinctive cerebral white matter changes are characteristic of ALD.
  • Nonspecific or absent abnormalities on CT may be observed in AMN, highlighting the need for clinical correlation.

    • Implications:

    • Recognizing the specific CT patterns associated with ALD and AMN can aid in the early diagnosis of these rare neurological diseases.
    • This differential diagnostic approach can guide clinicians in selecting appropriate biochemical tests for confirmation.
    • Categorizing the disease process accurately is essential for understanding the natural history and potential therapeutic strategies for leukodystrophies.